Assembly Biosciences Inc. (NASDAQ: ASMB) reported positive interim results from Phase 1b studies of two experimental herpes simplex virus treatments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE